Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Divyaansh Raj, Pranjal Agrawal, Hallie Gaitsch, Elizabeth Wicks & Betty Tyler. (2021) Pharmacological strategies for improving the prognosis of glioblastoma. Expert Opinion on Pharmacotherapy 22:15, pages 2019-2031.
Read now
Read now
Changling Li, Ting Liu, Bo Zhou, Yubin Zhou, Huiying Yu & Yun Sun. (2018) Efficacy and safety analysis on dendritic cell-based vaccine-treated high-grade glioma patients: a systematic review and meta-analysis. OncoTargets and Therapy 11, pages 7277-7293.
Read now
Read now
Phuc Van Pham, Hanh Thi Le, Binh Thanh Vu, Viet Quoc Pham, Phong Minh Le, Nhan Lu-Chinh Phan, Ngu Van Trinh, Huyen Thi-Lam Nguyen, Sinh Truong Nguyen, Toan Linh Nguyen & Ngoc Kim Phan. (2016) Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results. OncoTargets and Therapy 9, pages 4441-4451.
Read now
Read now
Articles from other publishers (29)
Qiujun Qiu, Xinyi Ding, Jixiang Chen, Sunhui Chen & Jianxin Wang. (2023) Nanobiotechnology-based treatment strategies for malignant relapsed glioma. Journal of Controlled Release 358, pages 681-705.
Crossref
Crossref
Masoumeh Najafi, Amin Jahanbakhshi, Sebastiano Finocchi Ghersi, Lucia Giaccherini, Andrea Botti, Francesco Cavallieri, Jessica Rossi, Federico Iori, Cinzia Iotti, Patrizia Ciammella, Mohsen Nabiuni, Marzieh Gomar, Omid Rezaie & Salvatore Cozzi. (2023) Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review. Brain Sciences 13:2, pages 159.
Crossref
Crossref
Stefaan W. Van Gool, Peter Van de Vliet, Linde F.C. Kampers, Jennifer Kosmal, Tobias Sprenger, Ella Reich, Volker Schirrmacher & Wilfried Stuecker. 2023.
Tianzhong Li, Jingfeng Li, Zhi Chen, Shaohui Zhang, Shunling Li, S. Wageh, Omar A. Al-Hartomy, Abdullah G. Al-Sehemi, Zhongjian Xie, Ranjith Kumar Kankala & Han Zhang. (2022) Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions. Journal of Controlled Release 352, pages 338-370.
Crossref
Crossref
Stefaan W. Van Gool, Jennifer Makalowski, Michael Bitar, Peter Van de Vliet, Volker Schirrmacher & Wilfried Stuecker. (2022) Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients. Genes & Immunity 23:8, pages 255-259.
Crossref
Crossref
Asim Hussain, Hamza Rafeeq, Nimra Munir, Zara Jabeen, Nadia Afsheen, Khalil ur Rehman, Muhammad Bilal & Hafiz M. N. Iqbal. (2021) Dendritic Cell–Targeted Therapies to Treat Neurological Disorders. Molecular Neurobiology 59:1, pages 603-619.
Crossref
Crossref
Jeaneen Venkatas & Moganavelli Singh. (2021) Nanomedicine-mediated optimization of immunotherapeutic approaches in cervical cancer. Nanomedicine 16:15, pages 1311-1328.
Crossref
Crossref
Stefaan W. Van Gool, Jennifer Makalowski, Simon Fiore, Tobias Sprenger, Lothar Prix, Volker Schirrmacher & Wilfried Stuecker. (2020) Randomized Controlled Immunotherapy Clinical Trials for GBM Challenged. Cancers 13:1, pages 32.
Crossref
Crossref
Li Lv, Jiangchao Huang, Haipeng Xi & Xiangyang Zhou. (2020) Efficacy and safety of dendritic cell vaccines for patients with glioblastoma: A meta-analysis of randomized controlled trials. International Immunopharmacology 83, pages 106336.
Crossref
Crossref
Jun-Xia Cao, Wei-Jian Gao, Jia You, Li-Hua Wu & Zheng-Xu Wang. (2020) Assessment of the efficacy of passive cellular immunotherapy for glioma patients. Reviews in the Neurosciences 31:4, pages 427-440.
Crossref
Crossref
Miquel Lozano, Joan Cid, Daniel Benitez-Ribas & Manel Juan Otero. (2019) Technical Challenges in the Manufacture of Dendritic Cell Cancer Therapies. European Oncology & Haematology 15:1, pages 22.
Crossref
Crossref
Aleksei Stepanenko & Vladimir Chekhonin. (2018) Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?. Cancers 10:12, pages 492.
Crossref
Crossref
Julius W. Kim, J. Robert Kane, Wojciech K. Panek, Jacob S. Young, Aida Rashidi, Dou Yu, Deepak Kanojia, Tanwir Hasan, Jason Miska, Miguel A. Gómez-Lim, Ilya V. Ulasov, Irina V. Balyasnikova, Atique U. Ahmed, Derek A. Wainwright & Maciej S. Lesniak. (2018) A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. Neurotherapeutics 15:4, pages 1127-1138.
Crossref
Crossref
Chia-Ing Jan, Wan-Chen Tsai, Horng-Jyh Harn, Woei-Cherng Shyu, Ming-Chao Liu, Hsin-Man Lu, Shao-Chih Chiu & Der-Yang Cho. (2018) Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme. Frontiers in Immunology 9.
Crossref
Crossref
Pedro R. Lowenstein & Maria G. Castro. (2018) Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients. Clinical Immunology 189, pages 43-51.
Crossref
Crossref
Richard G. Everson & Linda M. Liau. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
681
692
.
Bing Li, Chun Zhou, Liang Yi, Lunshan Xu & Minhui Xu. (2017) Effect and molecular mechanism of mTOR inhibitor rapamycin on temozolomide‑induced autophagic death of U251 glioma cells. Oncology Letters.
Crossref
Crossref
Emilie De Carli, Matthieu Delion & Audrey Rousseau. (2017) Immunothérapie des tumeurs cérébrales. Annales de Pathologie 37:1, pages 117-126.
Crossref
Crossref
David A. Reardon & Duane A. Mitchell. (2017) The development of dendritic cell vaccine-based immunotherapies for glioblastoma. Seminars in Immunopathology 39:2, pages 225-239.
Crossref
Crossref
R.G. Everson, J.P. Antonios, A.M. Tucker & L.M. Liau. 2017. Translational Immunotherapy of Brain Tumors. Translational Immunotherapy of Brain Tumors
301
321
.
Amanda Tivnan, Tatjana Heilinger, Ed C. Lavelle & Jochen H. M. Prehn. (2016) Advances in immunotherapy for the treatment of glioblastoma. Journal of Neuro-Oncology 131:1, pages 1-9.
Crossref
Crossref
Yingge Wang, Shan Gao, Weiguang Wang & Jingyan Liang. (2016) Temozolomide inhibits cellular growth and motility via targeting ERK signaling in glioma C6 cells. Molecular Medicine Reports 14:6, pages 5732-5738.
Crossref
Crossref
Paul R. Gielen, Barbara M. Schulte, Esther D. Kers-Rebel, Kiek Verrijp, Sandra A.J.F.H. Bossman, Mark ter Laan, Pieter Wesseling & Gosse J. Adema. (2016) Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function. Neuro-Oncology 18:9, pages 1253-1264.
Crossref
Crossref
Peter Ludewig, Mattia Gallizioli, Xabier Urra, Sarah Behr, Vanessa H. Brait, Mathias Gelderblom, Tim Magnus & Anna M. Planas. (2016) Dendritic cells in brain diseases. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1862:3, pages 352-367.
Crossref
Crossref
Wenjuan Chen, Li Zhang, Yan Wang, Jie Sun, Donglin Wang, Shaochen Fan, Na Ban, Junya Zhu, Bin Ji & Yuchan Wang. (2015) Expression of CDC5L is associated with tumor progression in gliomas. Tumor Biology 37:3, pages 4093-4103.
Crossref
Crossref
Ming Li, Shuangyin Han & Xiwen Shi. (2015) In situ dendritic cell vaccination for the treatment of glioma and literature review. Tumor Biology 37:2, pages 1797-1801.
Crossref
Crossref
Sébastien Anguille, Evelien L. Smits, Christian Bryant, Heleen H. Van Acker, Herman Goossens, Eva Lion, Phillip D. Fromm, Derek N. Hart, Viggo F. Van Tendeloo & Zwi N. Berneman. (2015) Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy. Pharmacological Reviews 67:4, pages 731-753.
Crossref
Crossref
C von Neubeck, A Seidlitz, H H Kitzler, B Beuthien-Baumann & M Krause. (2015) Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs. The British Journal of Radiology 88:1053, pages 20150354.
Crossref
Crossref
Nolan Ung & Isaac Yang. (2015) Nanotechnology to augment immunotherapy for the treatment of glioblastoma multiforme. Journal of Neuro-Oncology 123:3, pages 473-481.
Crossref
Crossref